Long-Term Liabilities to Equity: Axonics, Inc (AXNX)

Official company branding of Axonics, Inc (AXNX)

Axonics, Inc. (AXNX) neuromodulator production is based on a fabless approach utilizing Asian and American plants. This chart illustrates the asset's price action, with operating profit currently at 0.26. The business depends on implant sales in clinics and the approval of new devices; meanwhile, trade conflicts and inflation are driving up electronics costs, reducing demand for elective surgeries in the US.

Axonics Modulation Technologies (AXNX): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for Axonics, Inc. (AXNX)

- price and consensus price forecast:
Market Chart Axonics Inc.|AXNX - Price Target Chart
- market capitalization data:
Market Valuation Axonics, Inc.|AXNX - Enterprise Value
- book capitalization data:
Net Asset Value per Share Axonics|AXNX - Book Capitalization|Market Cap to Net Assets Ratio axonics.com|AXNX - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Axonics, Inc.|AXNX - Long-Term Debt to Capital|Short-Term Debt to Capital axonics.com|AXNX - Company Debts|Debt to Book Capitalization Ratio Axonics, Inc.|AXNX - Company Long-Term Debts|Short-Term Debt Volume Axonics
Comprehensive company analysis:AXNX, Axonics Inc.
Core merchandise of Axonics, Inc.

This ratio assesses long-term leverage by comparing liabilities with maturities exceeding one year against total equity. The metric determines the extent to which financial stability depends on borrowed funds. The current long-term debt-to-equity ratio is 0.26. Low debt leverage underscores the fundamental strength of Axonics, Inc. (AXNX). Patent protection for neuromodulators and integration with Boston Scientific make such conservatism a strategic advantage during expansion.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital SI-BONE Corp (SIBN)|Long-Term Debt to Capital Ratio Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Long-Term Debt to Capital|RXST - Long-Term Liabilities to Capital|Long-Term Debt to Capital clearpointneuro.com|stereotaxis.com (STXS) - Long-Term Debt to Capital Ratio|STIM: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Sight Sciences Inc.|Long-Term Debt to Capital OBIO (Orchestra BioMed)|Long-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Long-Term Debt to Capital|VANI - Long-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital MYO (Myomo, Inc.)|Long-Term Liabilities to Capital COCH|VVOS: Long-Term Debt to Equity|Long-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Long-Term Debt to Equity Ratio SINT (Sintx Technologies, Inc.)|Long-Term Debt to Capital Tenon Medical Inc TNON|Long-Term Debt to Capital LFWD (ReWalk Robotics Ltd.)|AMIX: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity INVO Fertility (IVF)|BBLG (Bone Biologics Corp.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)